Luisa Agnello

Palermo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.

Toward harmonized reporting of Alzheimer's disease biomarkers in clinical practice.

Journal: Clinical chemistry and laboratory medicine

Published: July 08, 2026

A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome.

A rapid, accessible real-time PCR approach to identify UBA1 somatic mutations in VEXAS syndrome.

Journal: Frontiers in medicine

Published: April 17, 2026

Analytical Methods for Fluid Biomarkers in Alzheimer's Disease from Discovery to Clinical Implementation.

Analytical Methods for Fluid Biomarkers in Alzheimer's Disease from Discovery to Clinical Implementation.

Journal: International journal of molecular sciences

Published: April 16, 2026

Exploring the role of circulating glial fibrillary acidic protein and neurofilament light chain in myasthenia gravis.

Exploring the role of circulating glial fibrillary acidic protein and neurofilament light chain in myasthenia gravis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: March 17, 2026

Inflammasome Gene Polymorphisms (NLRP3 and NLRC4) and Vitamin D Status in Patients with Multiple Sclerosis.

Inflammasome Gene Polymorphisms (NLRP3 and NLRC4) and Vitamin D Status in Patients with Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: March 09, 2026

Exploring Early Neurodegeneration Through Fasting-Induced Metabolic Signatures and High-Sensitivity Biomarkers.

Exploring Early Neurodegeneration Through Fasting-Induced Metabolic Signatures and High-Sensitivity Biomarkers.

Journal: Current issues in molecular biology

Published: February 17, 2026

Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).

Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).

Journal: Aging

Published: February 09, 2026

Current practices and harmonization challenges in Alzheimer's disease biomarkers: an EFLM Committee: Harmonization Survey.

Current practices and harmonization challenges in Alzheimer's disease biomarkers: an EFLM Committee: Harmonization Survey.

Journal: Clinical chemistry and laboratory medicine

Published: January 31, 2026

Diagnostic and Prognostic Value of Serum Glial Fibrillary Acidic Protein in Acute Ischemic Stroke.

Diagnostic and Prognostic Value of Serum Glial Fibrillary Acidic Protein in Acute Ischemic Stroke.

Journal: Journal of clinical medicine

Published: January 22, 2026

Serum neurofilament light chain and glial fibrillary acidic protein predicting multiple sclerosis after clinically isolated syndrome.

Serum neurofilament light chain and glial fibrillary acidic protein predicting multiple sclerosis after clinically isolated syndrome.

Journal: Journal of neurology

Published: December 09, 2025

Blood-based biomarkers for Alzheimer's disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine(SIBioC) and from the Autonomous Association affiliated with SIN for dementia (SINdem).

Blood-based biomarkers for Alzheimer's disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine(SIBioC) and from the Autonomous Association affiliated with SIN for dementia (SINdem).

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: November 28, 2025

Evaluation of Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in Cerebrospinal Fluid, Serum, and Plasma Using the Fully Automated Lumipulse Platform.

Evaluation of Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) in Cerebrospinal Fluid, Serum, and Plasma Using the Fully Automated Lumipulse Platform.

Journal: Journal of clinical laboratory analysis

Published: November 24, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026